Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276.SH) has announced its first buyback of A-shares, executed through centralized bidding transactions on September 17, 2026.

During this transaction, the company repurchased a total of 335,000 shares, accounting for 0.005% of its overall share capital. The shares were acquired at a maximum price of 43.58 yuan per share and a minimum price of 43.10 yuan per share.

The aggregate amount paid for this repurchase reached 14.5036 million yuan, excluding transaction fees.